WallStreetZenWallStreetZen

NASDAQ: ANAB
Anaptysbio Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ANAB past revenue growth

How has ANAB's revenue growth performed historically?
Company
66.78%
Industry
142.27%
Market
17.7%
ANAB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ANAB's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ANAB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ANAB earnings and revenue history

Current Revenue
$17.2M
Current Earnings
-$163.6M
Current Profit Margin
-953.7%

ANAB Return on Equity

Current Company
-119.4%
Current Industry
-63.5%
Current Market
188%
ANAB's Return on Equity (-119.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ANAB announces earnings.

ANAB Return on Assets

Current Company
-32.6%
Current Industry
2.9%
ANAB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ANAB Return on Capital Employed

Current Company
-39.43%
Current Industry
19.5%
ANAB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ANAB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ANAB$17.16M-$161.25M-$163.62M+27.97%N/A
KYTX$0.00-$56.75M-$60.37M-100.00%N/A
NUVB$0.00-$75.65M-$75.80MN/AN/A
PHAR$266.65M$4.25M-$11.47M+11.91%N/A
HLVX$0.00-$119.02M-$123.57MN/AN/A
View Top Biotech Stocks

ANAB earnings dates

Next earnings date
Jun 12, 2024

Anaptysbio Earnings & Revenue FAQ

What were ANAB's earnings last quarter?

On Invalid Date, Anaptysbio (NASDAQ: ANAB) reported Q4 2023 earnings per share (EPS) of -$1.59, up 70.97% year over year. Total Anaptysbio earnings for the quarter were -$42.21 million. In the same quarter last year, Anaptysbio's earnings per share (EPS) was -$0.93.

If you're new to stock investing, here's how to buy Anaptysbio stock.

What was ANAB's earnings growth in the past year?

As of Q2 2024, Anaptysbio's earnings has grown year over year. Anaptysbio's earnings in the past year totalled -$163.62 million.

What is ANAB's earnings date?

Anaptysbio's earnings date is Invalid Date. Add ANAB to your watchlist to be reminded of ANAB's next earnings announcement.

What was ANAB's revenue last quarter?

On Invalid Date, Anaptysbio (NASDAQ: ANAB) reported Q4 2023 revenue of $9.01 million up 32.27% year over year. In the same quarter last year, Anaptysbio's revenue was $6.81 million.

What was ANAB's revenue growth in the past year?

As of Q2 2024, Anaptysbio's revenue has grown 66.78% year over year. This is 75.49 percentage points lower than the US Biotechnology industry revenue growth rate of 142.27%. Anaptysbio's revenue in the past year totalled $17.16 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.